Type 1 diabetes mellitus with mild nonproliferative diabetic retinopathy with macular edema (bilateral)
ICD-10 E10.3213 is a billable code used to indicate a diagnosis of type 1 diabetes mellitus with mild nonproliferative diabetic retinopathy with macular edema (bilateral).
E10.3213 refers to a specific condition in which a patient has Type 1 diabetes mellitus accompanied by mild nonproliferative diabetic retinopathy and bilateral macular edema. Type 1 diabetes is characterized by the autoimmune destruction of insulin-producing beta cells in the pancreas, leading to absolute insulin deficiency. Diabetic retinopathy is a common complication of diabetes, resulting from damage to the retinal blood vessels. In the case of mild nonproliferative diabetic retinopathy, there are early signs of retinal damage, such as microaneurysms and retinal hemorrhages, but no new blood vessel growth (neovascularization) is present. Macular edema, a condition where fluid accumulates in the macula, can lead to vision impairment. The presence of bilateral macular edema indicates that both eyes are affected, which can significantly impact the patient's quality of life. Management of this condition typically involves tight glycemic control, regular ophthalmologic evaluations, and possibly the use of anti-VEGF injections or laser therapy to address the macular edema.
Detailed records of diabetes management, including HbA1c levels and insulin regimen.
Patients presenting with uncontrolled diabetes, requiring insulin adjustments.
Ensure documentation reflects the patient's diabetes type and any complications.
Comprehensive eye exam reports detailing findings of retinopathy and macular edema.
Routine diabetic eye exams and treatment for diabetic retinopathy.
Document the severity of retinopathy and any interventions performed.
Used during routine eye exams for diabetic patients.
Complete eye exam documentation including findings.
Ophthalmologists must document the severity of retinopathy.
Accurate coding of E10.3213 is crucial for proper reimbursement, ensuring that patients receive appropriate care for their diabetes and its complications. It also aids in tracking the prevalence of diabetic retinopathy and informs treatment protocols.
